Sheena Singh, PhD

Title(s)Associate Specialist, Microbiology and Immunology
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Canadian Institutes of Health Research2012  - 2014Banting Postdoctoral Fellowship
    Canadian Institutes of Health Research2015  - 2016Postdoctoral Fellowship

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fox, E. P., Singh-Babak, S. D., Hartooni, N. & Nobile, C. J.Antifungals: From genomics to resistance and the development of Novel Agents. 2015; 71–90.
    2. Singh-Babak SD, Shekhar T, Smith AM, Giaever G, Nislow C, Cowen LE. A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae. Mol Biosyst. 2012 Oct; 8(10):2575-84. PMID: 22751784.
      View in: PubMed
    3. Singh-Babak SD, Babak T, Diezmann S, Hill JA, Xie JL, Chen YL, Poutanen SM, Rennie RP, Heitman J, Cowen LE. Global analysis of the evolution and mechanism of echinocandin resistance in Candida glabrata. PLoS Pathog. 2012; 8(5):e1002718. PMID: 22615574.
      View in: PubMed
    4. Singh SD, Robbins N, Zaas AK, Schell WA, Perfect JR, Cowen LE. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog. 2009 Jul; 5(7):e1000532. PMID: 19649312.
      View in: PubMed
    5. Cowen LE, Singh SD, Köhler JR, Collins C, Zaas AK, Schell WA, Aziz H, Mylonakis E, Perfect JR, Whitesell L, Lindquist S. Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2818-23. PMID: 19196973.
      View in: PubMed